MLYS · Mineralys Therapeutics, Inc.
← all insidersPharmaceutical Preparations · Listed on Nasdaq
Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
Open-market trades14
Distinct insiders4
Bought$0
Sold$6.46M
Net flow$-6.46M
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| Filed ↓Date the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | Warren Eric | Officer (Chief Commercial Officer) | M | ▼ sell10b5-1 | 7,437→ 7,437 Common Stock | — | — | 238,001 | — | — | filing |
| 2026-08-25 | Warren Eric | Officer (Chief Commercial Officer) | S | ▼ sell10b5-1 | 7,4370 | $25.98 | $193.2K | 38,400 | −16% | −<0.01% (now 0.04%) | filing |
| 2026-08-25 | Warren Eric | Officer (Chief Commercial Officer) | M | ▲ buy10b5-1 | 7,4370 | $13.24 | $98.5K | 45,837 | +19% | +<0.01% (now 0.05%) | filing |
| 2026-08-12 | Ferguson James J. III | Officer (Chief Medical Officer) | A | ▲ buy | 135,000→ 135,000 Common Stock | — | — | 135,000 | — | — | filing |
| 2026-08-12 | Ferguson James J. III | Officer (Chief Medical Officer) | A | ▲ buy | 102,4000 | — | — | 102,400 | new | +0.12% (now 0.12%) | filing |
| 2026-08-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 2,170→ 2,170 Common Stock | — | — | 13,024 | — | — | filing |
| 2026-08-12 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 2,1700 | $27.09 | $58.8K | 51,384 | −4% | −<0.01% (now 0.06%) | filing |
| 2026-08-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 2,1700 | $16.00 | $34.7K | 53,554 | +4% | +<0.01% (now 0.06%) | filing |
| 2026-07-23 | Warren Eric | Officer (Chief Commercial Officer) | M | ▼ sell10b5-1 | 7,438→ 7,438 Common Stock | — | — | 245,438 | — | — | filing |
| 2026-07-23 | Warren Eric | Officer (Chief Commercial Officer) | S | ▼ sell10b5-1 | 7,4380 | $26.87 | $199.9K | 38,400 | −16% | −<0.01% (now 0.04%) | filing |
| 2026-07-23 | Warren Eric | Officer (Chief Commercial Officer) | M | ▲ buy10b5-1 | 7,4380 | $13.24 | $98.5K | 45,838 | +19% | +<0.01% (now 0.05%) | filing |
| 2026-07-20 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 416→ 416 Common Stock | — | — | 3,334 | — | — | filing |
| 2026-07-20 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4160 | $26.53 | $11.0K | 51,384 | −0.8% | −<0.01% (now 0.06%) | filing |
| 2026-07-20 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4160 | $15.44 | $6.4K | 51,800 | +0.8% | +<0.01% (now 0.06%) | filing |
| 2026-07-15 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 10,7000 | $27.24 | $291.4K | 603,621 | −2% | −0.01% (now 0.68%) | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 6,349→ 6,349 Common Stock | — | — | 0 | — | — | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 4,167→ 4,167 Common Stock | — | — | 79,167 | — | — | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 3,542→ 3,542 Common Stock | — | — | 109,792 | — | — | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 6,3490 | $26.61 | $169.0K | 51,384 | −11% | −<0.01% (now 0.06%) | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 14,0580 | $27.58 | $387.7K | 57,733 | −20% | −0.02% (now 0.07%) | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 6,3490 | $1.08 | $6.9K | 71,791 | +10% | +<0.01% (now 0.08%) | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4,1670 | $14.25 | $59.4K | 65,442 | +7% | +<0.01% (now 0.07%) | filing |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 3,5420 | $10.20 | $36.1K | 61,275 | +6% | +<0.01% (now 0.07%) | filing |
| 2026-07-10 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 2,171→ 2,171 Common Stock | — | — | 15,194 | — | — | filing |
| 2026-07-10 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 2,1710 | $30.30 | $65.8K | 57,733 | −4% | −<0.01% (now 0.07%) | filing |
| 2026-07-10 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 2,1710 | $16.00 | $34.7K | 59,904 | +4% | +<0.01% (now 0.07%) | filing |
| 2026-06-30 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 17,0000 | $26.82 | $455.9K | 614,321 | −3% | −0.02% (now 0.69%) | filing |
| 2026-06-30 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 58,0000 | $25.94 | $1.50M | 631,321 | −8% | −0.07% (now 0.71%) | filing |
| 2026-06-30 | Warren Eric | Officer (Chief Commercial Officer) | M | ▼ sell10b5-1 | 104,124→ 104,124 Common Stock | — | — | 252,876 | — | — | filing |
| 2026-06-30 | Warren Eric | Officer (Chief Commercial Officer) | S | ▼ sell10b5-1 | 104,1240 | $25.90 | $2.70M | 38,400 | −73% | −0.12% (now 0.04%) | filing |
| 2026-06-30 | Warren Eric | Officer (Chief Commercial Officer) | M | ▲ buy10b5-1 | 104,1240 | $13.24 | $1.38M | 142,524 | 3.7× | +0.12% (now 0.16%) | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 417→ 417 Common Stock | — | — | 3,750 | — | — | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 4,167→ 4,167 Common Stock | — | — | 83,334 | — | — | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 3,542→ 3,542 Common Stock | — | — | 113,334 | — | — | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4,5840 | $25.00 | $114.6K | 57,095 | −7% | −<0.01% (now 0.06%) | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4170 | $15.44 | $6.4K | 61,679 | +0.7% | +<0.01% (now 0.07%) | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4,1670 | $14.25 | $59.4K | 61,262 | +7% | +<0.01% (now 0.07%) | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 9,8900 | $23.81 | $235.5K | 57,095 | −15% | −0.01% (now 0.06%) | filing |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 3,5420 | $10.20 | $36.1K | 66,985 | +6% | +<0.01% (now 0.08%) | filing |
| 2026-06-17 | Karydas Daphne | Director | M | ▼ sell10b5-1 | 3,000→ 3,000 Common Stock | — | — | 38,000 | — | — | filing |
| 2026-06-17 | Karydas Daphne | Director | S | ▼ sell10b5-1 | 3,0000 | $25.00 | $75.0K | 6,200 | −33% | −<0.01% (now <0.01%) | filing |
| 2026-06-17 | Karydas Daphne | Director | M | ▲ buy10b5-1 | 3,0000 | $12.02 | $36.1K | 9,200 | +48% | +<0.01% (now 0.01%) | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 6,349→ 6,349 Common Stock | — | — | 6,349 | — | — | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 2,170→ 2,170 Common Stock | — | — | 17,365 | — | — | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 6,3490 | $23.93 | $151.9K | 63,443 | −9% | −<0.01% (now 0.07%) | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 6,3490 | $1.08 | $6.9K | 69,792 | +10% | +<0.01% (now 0.08%) | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 2,1700 | $25.00 | $54.3K | 63,443 | −3% | −<0.01% (now 0.07%) | filing |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 2,1700 | $16.00 | $34.7K | 65,613 | +3% | +<0.01% (now 0.07%) | filing |
| 2026-05-19 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 417→ 417 Common Stock | — | — | 4,167 | — | — | filing |
| 2026-05-19 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4170 | $27.55 | $11.5K | 63,443 | −0.7% | −<0.01% (now 0.07%) | filing |
| 2026-05-19 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4170 | $15.44 | $6.4K | 63,860 | +0.7% | +<0.01% (now 0.07%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 4,166→ 4,166 Common Stock | — | — | 87,501 | — | — | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 3,541→ 3,541 Common Stock | — | — | 116,876 | — | — | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 6,348→ 6,348 Common Stock | — | — | 12,698 | — | — | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 2,171→ 2,171 Common Stock | — | — | 19,535 | — | — | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 14,0560 | $28.58 | $401.8K | 63,443 | −18% | −0.02% (now 0.07%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4,1660 | $14.25 | $59.4K | 77,499 | +6% | +<0.01% (now 0.09%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 3,5410 | $10.20 | $36.1K | 73,333 | +5% | +<0.01% (now 0.08%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 6,3480 | $29.36 | $186.3K | 69,792 | −8% | −<0.01% (now 0.08%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 6,3480 | $1.08 | $6.9K | 76,140 | +9% | +<0.01% (now 0.09%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 2,1710 | $29.71 | $64.5K | 69,792 | −3% | −<0.01% (now 0.08%) | filing |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 2,1710 | $16.00 | $34.7K | 71,963 | +3% | +<0.01% (now 0.08%) | filing |
| 2026-04-21 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 416→ 416 Common Stock | — | — | 4,584 | — | — | filing |
| 2026-04-21 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4160 | $31.33 | $13.0K | 69,792 | −0.6% | −<0.01% (now 0.08%) | filing |
| 2026-04-21 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4160 | $15.44 | $6.4K | 70,208 | +0.6% | +<0.01% (now 0.08%) | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 4,167→ 4,167 Common Stock | — | — | 91,667 | — | — | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 3,542→ 3,542 Common Stock | — | — | 120,417 | — | — | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 6,349→ 6,349 Common Stock | — | — | 19,046 | — | — | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 6,3480 | $27.66 | $175.6K | 69,792 | −8% | −<0.01% (now 0.08%) | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 14,0580 | $26.54 | $373.1K | 76,140 | −16% | −0.02% (now 0.09%) | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 4,1670 | $14.25 | $59.4K | 90,198 | +5% | +<0.01% (now 0.10%) | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 3,5420 | $10.20 | $36.1K | 86,031 | +4% | +<0.01% (now 0.10%) | filing |
| 2026-04-15 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 6,3490 | $1.08 | $6.9K | 82,489 | +8% | +<0.01% (now 0.09%) | filing |
| 2026-04-15 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 15,7300 | $26.83 | $422.0K | 689,321 | −2% | −0.02% (now 0.78%) | filing |
| 2026-04-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▼ sell10b5-1 | 2,170→ 2,170 Common Stock | — | — | 21,706 | — | — | filing |
| 2026-04-13 | Rodman David Malcom | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 2,1700 | $27.38 | $59.4K | 76,140 | −3% | −<0.01% (now 0.09%) | filing |
| 2026-04-13 | Rodman David Malcom | Officer (Chief Medical Officer) | M | ▲ buy10b5-1 | 2,1700 | $16.00 | $34.7K | 78,310 | +3% | +<0.01% (now 0.09%) | filing |
| 2026-04-02 | Karydas Daphne | Director | M | ▼ sell10b5-1 | 3,000→ 3,000 Common Stock | — | — | 41,000 | — | — | filing |
| 2026-04-02 | Karydas Daphne | Director | S | ▼ sell10b5-1 | 3,0000 | $25.00 | $75.0K | 6,200 | −33% | −<0.01% (now <0.01%) | filing |
| 2026-04-02 | Karydas Daphne | Director | M | ▲ buy10b5-1 | 3,0000 | $12.02 | $36.1K | 9,200 | +48% | +<0.01% (now 0.01%) | filing |
| 2026-04-02 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 4530 | $27.05 | $12.3K | 705,051 | −<0.1% | −<0.01% (now 0.80%) | filing |
| 2026-04-02 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 55,1830 | $26.54 | $1.46M | 705,504 | −7% | −0.06% (now 0.80%) | filing |
| 2026-04-02 | Congleton Jon | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 19,3640 | $25.50 | $493.8K | 760,687 | −2% | −0.02% (now 0.86%) | filing |
| 2026-03-31 | RA CAPITAL MANAGEMENT, L.P. +4 more | Director | P | ▲ buy | 58,3000 | $24.16 | $1.41M | 5,825,521 | +1% | +0.07% (now 6.6%) | filing |
| 2026-03-31 | RA CAPITAL MANAGEMENT, L.P. +4 more | Director | P | ▲ buy | 310,7000 | $23.67 | $7.35M | 5,767,221 | +6% | +0.35% (now 6.5%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.